Certified by Founder Lodge 
                                        
                                        Attovia Therapeutics
 
                                                 United States  -  Fremont, California 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $105,000,000
                                            0 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format bip
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| May, 14 ,2024 | Series B | $105,000,000 | |
| April, 17 ,2025 | Series C | $90,000,000.00 | |
| April, 17 ,2025 | Series C | $90,000,000.00 | 
                                                
 Goldman Sachs
                                                                                
 Illumina Ventures
                                                                                
 Marshall Wace
                                                                                
                                                                            
 Redmile Group
                                                                                
 EcoR1 Capital, LLC
                                                                                
 Frazier Life Sciences
                                                                                
 Nextech Ventures
                                                                                
                                                                            
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
 
                                            
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)